J Pharmacol Sci 103 Supplement I (2007)

SL2
Frontiers of Life Science uncovered by Molecular Motors, Kinesin Superfamily Proteins, KIFs
Nobutaka Hirokawa .......... 4P

SL3
G-protein-mediated signalling pathways in vascular physiology and pathology
Stefan Offermanns .......... 5P

SL4
My Journey in Pharmacology, Prostanoid Receptors and Rho
Shuh Narumiya .......... 5P

SL5
The Mechanism of Action of Antipsychotic Drugs, and New Developments in the
Treatment of Schizophrenia (Tentative Title)
Herbert Meltzer .......... 6P

SL6
Ca2+ dynamics and intracellular signal transduction
Katsuhiko Mikoshiba .......... 6P

SL7
Cognition and Antidepressants: beyond behavioural toxicity.
Ian Hindmarch.......... 7P

SL8
Toward the identification of novel genes possibly involved in learning and memory
Remi Quirion, Jonathan brouillette .......... 7P

SL9
Integrative mechanisms of synaptic transmission in the neural network
Shigetada Nakanishi.......... 8P

Educational Lectures
EL-1
An Encouragement of Pharmacology and Toxicology -from Drug Discovery to Food
Safety-
Taku Nagao ............ 10P

EL2
Misconduct and Conflict of Interest in Science
Hideaki Karaki ............ 10P

Award Lectures
AL1
Study on the mechanism of neuropsychological abnormalities induced by drugs of abuse
Taku Nagai ............ 12P

AL2
Mechanisms of intractable neuropathic pain through ATP receptors
Makoto Tsuda ............. 12P

AL3
Roles of endogenous PACAP in the nervous system
Norihito Shintani ............. 13P

Symposia
S1A1
Basic and clinical developments of G protein-coupled receptors
Hitoshi Kurose and Akira Hirasawa ............. 16P

S1B1
Protein kinases as therapeutic targets
Kozo Kaibuchi .............17P

S1C1
"Bench to bedside" strategies for Alzheimer's disease: what's to be solved now ?
Chiyoko Inagaki and Shun Shimohama ............. 18P

S1D1
Diverse physiological and pharmacological functions of various fatty acids
Harumi Okuyama and Michio Hashimoto ............. 20P

S1A2
Life style-related diseases on the digestive system: from molecular mechanisms to
therapeutic strategies
Atsushi Nakajima and Koichiro Wada ............. 21P

S1B2
The role of the brain and autonomic nervous system in the regulation of physiological
adaptation: new regulatory factors and their application to clinical medicine
Nobuyuki Yanagihara and Noriaki Kondo ............. 22P

S1C2
Aspects of Schizophrenia from Multiple Approaches: From Candidate
Genes To Brain Functions and Clinic
Yukihiro Noda and Akemichi Baba ............. 24P

S2A1
Significance of Vascular Endothelial Cell Disorders in Life Style-Related Diseases and
Emergency Diseases
Katsuo Kamata and Yuichi Hattori............. 25P

S2B1
Current topics in the pharmacological research on bone metabolism
Akifumi Togari and Keiichi Ohya ............. 26P

S2C1
Pharmacogenomics of Cardiovascular Pharmacology
Hiroshi Iwao and Toshio Tanaka ............. 27P

S2D1
Basic and Clinical Aspects of Non-neuronal ACh
Takeshi Fujii and Koichiro Kawashima ............. 28P

S2A2
New Frontiers of Chemical Genetics
Masatoshi Hagiwara and Minoru Yoshida ............. 29P

S2B2
Development of new drugs targeting glial cells
Schuichi Koizumi and Yoshihisa Kudo ............. 31P

S2C2
The mechanisms of learning and memory and its impairment, and
development of new therapeutic drugs
Masayuki Hiramatsu and Norio Matsuki ............. 32P

S2D2
Pharmacological Approach to "Mibyou"
Takeshi Tadano and Takeshi Miyata ............. 33P

S2A3
Pathogical Analysis and Therapeutic Strategy for Brain Infarction
Yasuharu Sasaki and Hiroshi Katsuki ............. 35P

S2B3
Basic and Clinical Pharmacology of Renin-Angiotensin System: From Bench to Bedside
Shinichi Kobayashi and Toshitaka Nabeshima............. 36P

S2C3
Neuropsychotoxicity of abused drugs - clinical and basic research and drug development-
Kiyofumi Yamada and Shuji Kaneko ............. 37P

S2D3
New aspects of neurotransmitter transporter research
Toshihiro Dohi and Shigeo Kitayama ............. 39P

S3A1
Basic and clinical aspects for lower urinary tract disorders and the drugs
Ikunobu Muramatsu and Osamu Yokoyama ............. 40P

S3B1
Progress of cancer chemotherapy -From bench to bedside-
Katsushi Yamada and Ryozo Oishi ............. 41P

S3C1
A new challenge for developing novel drugs against neuropathic pain
Kazuhide Inoue and Tsutomu Tanabe ............. 42P

S3D1
Pharmacotherapy and QOL for stress-related psychiatric disorders
Hiroshi Takeda and Chiaki Kamei ............. 43P

S3B2
The current studies of neuronal death and neurodegenarative diseases
Hideaki Hara and Kazuhiro Takuma ............. 45P

S3C2
Actin cytoskeleton in nerve cells: Their roles in basic and clinical sciences
Kazuhiro Kohama and Tomoaki Shirao ............. 46P

S3D2
A role of CNS histamine in cognitive and psychomotor function
Hiroyuki Kamei and Kazuhiko Yanai ............. 47P

Excellent Mini Simposia ............. 50P

Free Communications
Oral Sessions.......... 66P
Poster Sessions .......... 124P

Author Index
Subject Index

Subscription/back issue orders: to Subscription Information

Copyright The Japanese Pharmacological Society

Copyright(C) The Japanese Pharmacological Society All Rights Reserved.